Dr. David Ornstein – committed to compassion + innovation

drornsteinThe diagnosis of a urologic problem can create a wave of anxiety, concern and need for immediate decisions. These challenges may seem insurmountable at first, but with compassionate and quality care, they can be overcome.

Our concern is for the whole patient. While we treat the disease, we are always attuned to the individual’s quality of life and lifestyle. It often surprises our patients that most people diagnosed with urologic disease, even those with urologic (kidney, ureteral, bladder, prostate, testicular) cancers can be cured without significant impact on long-term quality of life.

What makes the difference? First, the development of better diagnostic tests such as the PSA blood test and computer tomography have improved the ability to detect urologic diseases and cancers earlier, while they’re still at a curable stage. Secondly the development of the DaVinci surgical robotic system and advances in robotic surgical techniques have made it possible to not only cure most urologic cancers but also treat them in ways that do not cause excessive pain. Today most prostate cancer patients can be treated successfully while still maintaining normal bodily functions such as urinary control and erectile function. In many cases a kidney tumor can be removed without damaging the remaining healthy portion of the kidney thanks to these robotic procedures. Finally, the advent of new instrumentation for radiation therapy such as RapidArc with Calypso-guidance and TrueBeam have allowed many prostate cancer patients to avoid surgery but still receive curative therapy.

My goal, as a physician, is to provide care that provides the best possible chance for cure while minimizing risk for treatment-related discomfort and long-term side effects. In some cases treatment is not necessary and all that is needed is close monitoring. However, when treatment is necessary I strive to use the most effective treatment for the individual patient whether that be surgical, radiation or medical therapy. In other words, we want to provide the best outcome to help every patient live his or her life the way they want to. In addition to cutting edge technologies for diagnosis and treatment, this level of care can only be achieved through the mutual trust of a true doctor-patient partnership. That is my objective - and my privilege.

David K. Ornstein, M.D.
Board certified in Urology, Fellowship trained in Urologic Oncology

Award Winning Urologist

DrOrnsteinsmallDr. Ornstein has been recognized through multiple national awards for his clinical expertise in the care of patients with prostate and other urologic cancers as well as his skill as a robotic surgeon. He has been named as one of the "Best Doctors in America" for the past five consecutive years, and was ranked in the 99th percentile for the 2010 Press Ganey Patient Satisfaction Survey.

In 2008, he was also named as a Physician of Excellence by the Orange County Medical Association and a Top Urologist by the Consumer's Research Council of America. At the 2007 annual meeting of the American Urologic Association, Dr. Ornstein became the 6th recipient of the prestigious Investigator Award from the Society of Urologic Oncology. This award recognizes excellence in both research and clinical practice in the area of urologic oncology.

Dr. Ornstein is an internationally recognized urologist and robotic surgeon. He completed his urology training at Washington University in St. Louis and additional fellowship training in Urologic Oncology at the National Cancer Institute. He has more than a decade of experience caring for patients with urologic cancers as well as elevated PSA, hematuria (blood in the urine) and non-cancerous prostate problems. Dr. Ornstein has successfully completed over 750 robotic surgeries; including more than 550 robotic prostatectomies for prostate cancer.

A pioneer and innovator in the field of robotic surgery, he has published extensively on this topic in a variety of peer-reviewed medical journals. Dr. Ornstein has lectured and trained multiple robotic surgeons in the United States and around the world. He has performed several live robotic surgeries including one during a symposium at the Seoul National University Boramae Medical Center in South Korea. His published outcomes for robotic prostatectomy, robotic cystectomy and robotic partial nephrectomy are comparable to those from other leading academic medical centers. He also has significant experience with the latest radiation therapy techniques, including RadidArc with Calypso, TrueBeam and Cyberknife radiosurgery.

Improving Outcomes for Robotic Prostate Surgery

Experience counts! There is more and more scientific evidence that patient outcomes for prostate cancer surgery are directly related to the experience and skill of the surgeon. A recent survey of 72 prostate cancer surgeons demonstrated that the risk for cancer recurrence was reduced by 40% if the surgeon had performed more than 250 open radical prostatectomies. It has also been shown that complications are less in the hands of experienced surgeons. Robotic surgery is equally challenging to master and it has been demonstrated that the “learning curve” for robotic prostatectomy is a minimum of 250 cases. It has also been shown that experience is not the only determinant of surgical outcome since not all “high volume” surgeons achieve equally good results. Thus, when choosing a robotic surgeon it is not only important to ask about experience, but one should also ask about results.

Dr. Ornstein tracks his results carefully in order to help him continually improve his techniques so that he can provide his patients the best opportunity for successful outcomes.